Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phthalocyanine mouthwash and nasal spray for COVID-19 viral load reduction
RBR-8tygcz7Recruiting
- Sponsor
- Universidade Estadual de Londrina
- Start
- Nov 2020
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of phthalocyanine in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Universidade Estadual de Londrina. Primary endpoints: Clinical improvement, Reduction in viral load and 1 more. Started Nov 2020; status: recruiting.
02
Drugs
phthalocyanine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-8tygcz7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8tygcz7.